AstraZeneca said the “cornerstone” of the commitment would be a new weight management production facility for its oral GLP-1 ...

The move is likely to intensify speculation that Astrazeneca is preparing to drop its London listing for New York.

AstraZeneca has revealed plans to invest $50bn in the US by 2030 with the aim of reaching $80bn in total revenue by 2030, with 50 per cent generated in the US.

Drugmaker AstraZeneca said on Tuesday that it plans to invest $50.0bn in the US for medicines manufacturing and R&D by 2030.

Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...

STORY: AstraZeneca plans to invest $50 billion in the U.S. by 2030.The Anglo-Swedish drugs giant said Monday (July 21) that ...

AstraZeneca (NASDAQ: AZN) has unveiled plans to invest $50 billion in U.S. manufacturing and RD infrastructure by 2030, ...

AstraZeneca, a global pharmaceutical giant, has chosen Virginia for its largest-ever single manufacturing investment—but officials have yet to say exactly where in the state the facility will be built ...

AstraZeneca announced that it will invest $50 billion in the U.S. by 2030, including a multi-billion-dollar manufacturing ...

AstraZeneca CEO Sir Pascal Soriot explains the reasoning behind its $50 billion expansion of operations across the U.S.

Commerce Secretary Howard Lutnick said Trump's new tariff policies are focused on ending the U.S.'s reliance on foreign supply of key pharmaceutical products. "We are proud that AstraZeneca has made ...

Governor Glenn Youngkin announced AstraZeneca, a global biopharmaceutical company focused on the research, development, and ...